<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.drugs.v2.DrugRecordOutput xmlns:ns2="local" id="6018"><DrugName>dextromethorphan hydrobromide (sustained release)</DrugName><DrugNamesKey><Name id="42757641">dextromethorphan</Name></DrugNamesKey><DrugSynonyms><Name><Value>Delsym</Value></Name><Name><Value>dextromethorphan hydrobromide</Value></Name><Name><Value>dextromethorphan</Value><Types><Type>BANN</Type></Types></Name><Name><Value>Delysym</Value></Name><Name><Value>dextromethorphan hydrobromide (sustained release)</Value></Name><Name><Value>125-69-9</Value><Types><Type>CAS RN</Type></Types></Name><Name><Value>125-71-3</Value><Types><Type>CAS RN</Type></Types></Name></DrugSynonyms><CompanyOriginator id="22898">Fisons plc</CompanyOriginator><CompaniesPrimary><Company id="17562">McNeil Pharmaceuticals Inc</Company><Company id="19626">Sandoz Venezuela SA</Company><Company id="17102">Ilsung Pharmaceutical Co Ltd</Company><Company id="15336">UCB Celltech</Company></CompaniesPrimary><CrossReferences><SourceEntity id="6018" type="Drug"><TargetEntity id="137626" type="siDrug">Dextromethorphan hydrobromide</TargetEntity></SourceEntity><SourceEntity id="15336" type="Company"><TargetEntity id="5035523587" type="organizationId">UCB Celltech (UK Branch)</TargetEntity></SourceEntity><SourceEntity id="17102" type="Company"><TargetEntity id="4295881047" type="organizationId">Ilsung Pharmaceutical Co Ltd</TargetEntity></SourceEntity><SourceEntity id="17562" type="Company"><TargetEntity id="5035523337" type="organizationId">McNeil Pharmaceuticals Inc</TargetEntity></SourceEntity><SourceEntity id="19626" type="Company"><TargetEntity id="5035523472" type="organizationId">Novartis de Venezuela SA</TargetEntity></SourceEntity><SourceEntity id="22898" type="Company"><TargetEntity id="4295894800" type="organizationId">Fisons Ltd</TargetEntity></SourceEntity><SourceEntity id="82" type="ciIndication"><TargetEntity id="R05" type="ICD10"></TargetEntity><TargetEntity id="10011224" type="MEDDRA"></TargetEntity><TargetEntity id="D003371" type="MeSH"></TargetEntity><TargetEntity id="-62743552" type="omicsDisease"></TargetEntity><TargetEntity id="283" type="siCondition"></TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="L">Launched</PhaseHighest><PhaseHighestDetailed><FirstLaunched>Cough - US - Jul-1996</FirstLaunched></PhaseHighestDetailed><IndicationsPrimary><Indication id="82">Cough</Indication></IndicationsPrimary><ActionsSecondary><Action id="1625">Antitussive</Action><Action id="59620">Unspecified drug target</Action></ActionsSecondary><Technologies><Technology id="630">Stereochemistry</Technology><Technology id="589">Sustained release formulation</Technology><Technology id="762">Small molecule therapeutic</Technology></Technologies><EphmraCodes><Ephmra><Code>R5D</Code><Name>ANTITUSSIVES</Name></Ephmra></EphmraCodes><LastModificationDate>2017-12-10T11:17:55.000Z</LastModificationDate><ChangeDateLast>2017-12-11T00:00:00.000Z</ChangeDateLast><AddedDate>1996-02-16T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;Dextomethorphan hydrobromide, sustained release, is an antitussive, originally developed by Fisons for the treatment of coughs [&lt;ulink linkID="214523" linkType="reference"&gt;214523&lt;/ulink&gt;]. The compound has been launched in the US, Venezuela and South Korea [&lt;ulink linkID="213953" linkType="reference"&gt;213953&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="19626">Sandoz Venezuela SA</Company><Country id="VE">Venezuela</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="82">Cough</Indication></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="15336">UCB Celltech</Company><Country id="US">US</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="82">Cough</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v2.drugs.soap.contract.service.ls.thomsonreuters.com/">1996-07-23T00:00:00.000Z</StatusDate><Source id="213953" type="PR"></Source></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="17562">McNeil Pharmaceuticals Inc</Company><Country id="US">US</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="82">Cough</Indication></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="17102">Ilsung Pharmaceutical Co Ltd</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="L" sortOrder="15">Launched</DevelopmentStatus><Indication id="82">Cough</Indication></DevelopmentStatusCurrent></IDdbDevelopmentStatus><ReasonsForUpdate><ReasonForUpdate><Reason>Editorial Amendments</Reason><Description>Minor editorial amendment</Description></ReasonForUpdate></ReasonsForUpdate><CountsByCompanies><Company><Company id="1009547">Sanofi SA</Company><CountAsPrincipalActive>0</CountAsPrincipalActive><CountAsPrincipalInactive>0</CountAsPrincipalInactive><CountAsPartnerActive>0</CountAsPartnerActive><CountAsPartnerInactive>0</CountAsPartnerInactive><CountTotal>1</CountTotal></Company><Company><Company id="20452">UCB SA</Company><CountAsPrincipalActive>1</CountAsPrincipalActive><CountAsPrincipalInactive>0</CountAsPrincipalInactive><CountAsPartnerActive>1</CountAsPartnerActive><CountAsPartnerInactive>0</CountAsPartnerInactive><CountTotal>1</CountTotal></Company></CountsByCompanies><CountsByTypes><Type><Type sortOrder="14">Drug - Asset Divestment</Type><CountActive>1</CountActive><CountInactive>0</CountInactive><CountTotal>1</CountTotal></Type></CountsByTypes><StructureSmiles><Smiles>CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc4c3cc(cc4)OC</Smiles><Smiles>CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc4c3cc(cc4)OC.Br</Smiles></StructureSmiles><Deals><Deal id="121379" title="Medeva to acquire Rhone-Poulnc Rorer's products including dextromethorphan hydrobromide "></Deal></Deals><PatentFamilies><PatentFamily id="1033681" number="WO-02100434" title="Treatment of neuropathic pain with N-methyl-D-aspartate (NMDA) receptor antagonists"></PatentFamily><PatentFamily id="1102380" number="CN-01732938" title="Orally disintegrating tablet of compound paracetamol"></PatentFamily><PatentFamily id="1206846" number="WO-09817268" title="Method of alleviating pain by means of combining tramadol with an NMDA antagonist."></PatentFamily><PatentFamily id="1214515" number="WO-03088952" title="Sustained release of guaifenesin combination drugs"></PatentFamily><PatentFamily id="1269164" number="CN-102600210" title="A compound dextromethorphan hydrobromide syrup and its preparation method"></PatentFamily><PatentFamily id="130927" number="US-05302394" title="Dextromethorphan Continuous Lozenge Manufacturing Process"></PatentFamily><PatentFamily id="1314318" number="CN-01775213" title="Dextromethorphan hydrobromide nose drops"></PatentFamily><PatentFamily id="1397443" number="WO-2006063189" title="Quick disintegrating drug delivery system"></PatentFamily><PatentFamily id="1466620" number="CN-01360892" title="Dry mixed suspension of meptin and pseudoephe and its prepn"></PatentFamily><PatentFamily id="1473474" number="WO-2007122580" title="Compositions and methods useful for treatment of respiratory illness"></PatentFamily><PatentFamily id="1544974" number="CN-01823770" title="Compound dextromethorphan oral cavity disintegration tablet"></PatentFamily><PatentFamily id="1565860" number="CN-102579926" title="Formula of cough medicine and preparation method thereof"></PatentFamily><PatentFamily id="1690600" number="CN-01634060" title="Gelatin formulation of dextromethorphan hydrobromide and its preparing method"></PatentFamily><PatentFamily id="1744119" number="BG-00065674" title="Liquid form of combined medicamentous preparation for the treatment of colds and flu diseases"></PatentFamily><PatentFamily id="1775746" number="CN-101352440" title="Guaifenesin, pseudoephedrine hydrochloride and dextromethorphan hydrobromide sustained-release preparation and preparation method thereof"></PatentFamily><PatentFamily id="1862699" number="EP-00081823" title="Composition For Reducing Menstrual Pain"></PatentFamily><PatentFamily id="1948320" number="WO-00029023" title="COX-2 inhibitors in combination with NMDA-blockers for treating pain"></PatentFamily><PatentFamily id="1994003" number="CN-01969850" title="Taste masked suspension prescription for treating infant cold and method for preparing same"></PatentFamily><PatentFamily id="2002811" number="WO-2011081625" title="Melt extruded thin strips containing coated pharmaceutical actives"></PatentFamily><PatentFamily id="2005265" number="WO-2011034554" title="A sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti -inflammatory drug"></PatentFamily><PatentFamily id="2024045" number="JP-57156412" title="Preparation containing dextromethorphan hydrobromide"></PatentFamily><PatentFamily id="2103305" number="WO-2004096174" title="Fast dissolving orally consumable films containing pharmaceutically active agents"></PatentFamily><PatentFamily id="210559" number="CN-01589794" title="Hydrobromic acid dextromethaphen oral cavity disintegretion tablet and its preparation method"></PatentFamily><PatentFamily id="212697" number="CN-01793904" title="Simultaneous determination of racemic methyl ephedrine hydrochloride, hydrobromide dextromethorphan and chlorpheniramine maleate combined method."></PatentFamily><PatentFamily id="2143869" number="CN-101756918" title="Paracetamol, pseudoephedrine hydrochloride and dextromethorphan hydrobromide compounded oral disintegrating tablet and preparation method thereof"></PatentFamily><PatentFamily id="2307160" number="EP-00225615" title="Resinate sustained release dextromethorphan composition"></PatentFamily><PatentFamily id="2360335" number="WO-03078399" title="Process for asymmetric hydrogenation of hexahydroquinoline salts"></PatentFamily><PatentFamily id="2398091" number="CN-102755304" title="Preparation method of guaifenesin and dextromethorphan hydrobromide capsule"></PatentFamily><PatentFamily id="2447872" number="US-08557784" title="Glycyrrhizinates of morphinan derivatives"></PatentFamily><PatentFamily id="2495295" number="US-20130071476" title="Rapid melt controlled release taste-masked compositions"></PatentFamily><PatentFamily id="2533124" number="WO-2004006930" title="Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders"></PatentFamily><PatentFamily id="2534077" number="CN-103110631" title="Compound phenol magnesium hemp sensitive slow release preparation and preparation method thereof"></PatentFamily><PatentFamily id="2534078" number="CN-103110630" title="Phenol compound sensitive capsule and preparation method thereof"></PatentFamily><PatentFamily id="2534079" number="CN-103110629" title="Compound phenol caplets dropping pills and preparation method thereof"></PatentFamily><PatentFamily id="2534080" number="CN-103110628" title="Phenol compound sensitive dispersible tablet and preparation method thereof"></PatentFamily><PatentFamily id="2547381" number="CN-103127113" title="Phenol compound sensitive dry suspension agent and preparation method thereof"></PatentFamily><PatentFamily id="2555503" number="CN-103156852" title="A one phenol sensitive enteric capsule and preparation method thereof"></PatentFamily><PatentFamily id="2555504" number="CN-103156851" title="A phenol one -sensitive slow release granule and preparation method thereof"></PatentFamily><PatentFamily id="2559830" number="CN-103169706" title="Of one pair comprising acetaminophen and oral disintegrating tablet and dextromethorphan"></PatentFamily><PatentFamily id="2559831" number="CN-103169705" title="Compound orally disintegrating tablet containing chlorpheniramine and dextromethorphan"></PatentFamily><PatentFamily id="2575697" number="CN-103211783" title="Dextromethorphan film control sustained-release pellet capsule"></PatentFamily><PatentFamily id="2583920" number="CN-102977021" title="Preparation method of dextromethorphan hydrobromide"></PatentFamily><PatentFamily id="2625035" number="CN-103191116" title="A kind of hydrogen bromide acid and dextromethorphan guaiacol glycerin ether oral liquid and preparation method thereof"></PatentFamily><PatentFamily id="2681112" number="CN-103432491" title="Pharmaceutical composition"></PatentFamily><PatentFamily id="2681114" number="CN-103432489" title="Pharmaceutical composition containing dextromethorphan hydrobromide"></PatentFamily><PatentFamily id="2685267" number="CN-103565735" title="One containing dextromethorphan hydrobromide oral solution and its preparation method"></PatentFamily><PatentFamily id="2686504" number="CN-103446518" title="One containing dextromethorphan hydrobromide pharmaceutical composition"></PatentFamily><PatentFamily id="2686853" number="CN-103446153" title="A kind of one composition and soft capsule treating cold and night"></PatentFamily><PatentFamily id="2690487" number="CN-103463088" title="Daytime-taken composition and softgel for treating cold "></PatentFamily><PatentFamily id="2690488" number="CN-103463087" title="Preparation method of night cold-treating soft capsules "></PatentFamily><PatentFamily id="2690641" number="CN-103462927" title="Preparation method for daytime-taken softgel for treating cold "></PatentFamily><PatentFamily id="2708616" number="CN-103536539" title="Dextromethorphan hydrobromide freeze-dry powder needle and preparation method thereof"></PatentFamily><PatentFamily id="2708628" number="CN-103536527" title="Dextromethorphan hydrobromide injection and its preparation method"></PatentFamily><PatentFamily id="2747359" number="CN-103705493" title="Dextromethorphan hydrobromide oral dispersible film agent and preparation method thereof"></PatentFamily><PatentFamily id="2794499" number="CN-104003936" title="One of dextromethorphan hydrobromide and refined purification method"></PatentFamily><PatentFamily id="2796603" number="WO-2014138669" title="Pain medicine combination and uses thereof"></PatentFamily><PatentFamily id="283507" number="CN-01616102" title="Compound dry suspensoid agent for curing cold and its prescription and preparing method"></PatentFamily><PatentFamily id="2838305" number="CN-104013606" title="Dextromethorphan hydrobromide agent and its preparation method"></PatentFamily><PatentFamily id="2843250" number="CN-104027445" title="Children's cold medicine and its preparation method containing fruit ingredient"></PatentFamily><PatentFamily id="2931699" number="CN-104490813" title="Dextromethorphan hydrobromide composition chewable tablet and its preparation method"></PatentFamily><PatentFamily id="2949100" number="WO-2015078382" title="Endo-(14&lt;i&gt;S&lt;/i&gt;)-3-methoxy-17-methylmorphinan picrate and preparation method and use thereof"></PatentFamily><PatentFamily id="3033346" number="CN-104888171" title="An expectorant and antiasthmatic decoction and preparation technique"></PatentFamily><PatentFamily id="3048348" number="CN-104940862" title="Cough-relieving decoction and preparation method"></PatentFamily><PatentFamily id="3127637" number="CN-105250755" title="Medicine for Chinese and western medicine treatment of bronchitis and preparation method thereof"></PatentFamily><PatentFamily id="3182842" number="CN-105524971" title="New method for enzymatic resolution of 1-(4 methoxy benzyl)-1, 2, 3, 4, 5, 6, 7, 8-octahydro-isoquinoline"></PatentFamily><PatentFamily id="3261367" number="CN-105769908" title="A medicine for eliminating phlegm and stopping cough and its preparation method"></PatentFamily><PatentFamily id="3388177" number="WO-2016154503" title="Liquisoft capsules"></PatentFamily><PatentFamily id="3485501" number="CN-106176749" title="Application of a pseudoephedrine hydrochloride tablet in preparing medicine for treating asthma"></PatentFamily><PatentFamily id="3493015" number="CN-106214679" title="Phenol paracetamol soft capsule medicine and preparation method thereof"></PatentFamily><PatentFamily id="3513582" number="CN-106279191" title="Related substance in dextromethorphan hydrobromide and guaiacol glyceryl ether granule and analyzing and detecting method thereof"></PatentFamily><PatentFamily id="3524279" number="CN-106267220" title="Guaifenesin, dextromethorphan hydrobromide anhydrous masking preparation"></PatentFamily><PatentFamily id="3596839" number="CN-106539774" title="A dextromethorphan hydrobromide oral disintegrating tablet and preparation method thereof"></PatentFamily><PatentFamily id="3649128" number="CN-106668193" title="A compound preparation for treating leukotrichia"></PatentFamily><PatentFamily id="3678552" number="CN-106727563" title="Western medicine composition for treating fracture"></PatentFamily><PatentFamily id="367891" number="CN-101744820" title="Pharmaceutical composition containing dextromethorphan hydrobromide"></PatentFamily><PatentFamily id="3832123" number="CN-107260739" title="Application of dextromethorphan hydrobromide to treatment of acute and chronic renal fibrosis"></PatentFamily><PatentFamily id="3960501" number="CN-107669891" title="A compound medicine for treating senile chronic bronchitis and preparation method thereof"></PatentFamily><PatentFamily id="3970110" number="CN-107693582" title="A pharmaceutical composition for treating cold and upper respiratory tract infection, preparation method and use thereof"></PatentFamily><PatentFamily id="3981281" number="CN-107782809" title="Method of detecting six active ingredient in the drug sample"></PatentFamily><PatentFamily id="4206195" number="WO-2018183203" title="Packaged multi-dose liquid drug formulation"></PatentFamily><PatentFamily id="4335063" number="CN-109044968" title="Paracetamol right renin beautifying oral liquid and preparation method thereof"></PatentFamily><PatentFamily id="4339039" number="CN-109010341" title="A compound oral solution containing dextromethorphan hydrobromide and preparation method thereof"></PatentFamily><PatentFamily id="443217" number="CN-101658500" title="A dextromethorphan hydrobromide sustained release tablet and preparation method"></PatentFamily><PatentFamily id="4510565" number="CN-109700758" title="Dextromethorphan hydrobromide syrup and preparation method thereof"></PatentFamily><PatentFamily id="4530518" number="CN-109771372" title="A dextromethorphan hydrobromide sustained release suspension and preparation method thereof"></PatentFamily><PatentFamily id="466404" number="EP-00911039" title="Drug-resin complexes stabilized by chelating agents"></PatentFamily><PatentFamily id="494246" number="WO-2004089352" title="Pharmaceutical combination for the treatment of spasticity and/or pain"></PatentFamily><PatentFamily id="559747" number="CN-01200709" title="Dextromethorphan hydrobromide drop pills and preparation process thereof"></PatentFamily><PatentFamily id="650353" number="CN-102219737" title="Preparation craft of cough medicine dextromethorphan hydrobromide key intermediate 1-(4-methoxy) benzyl-1, 2, 3, 4, 5, 6, 7, 8-hydrogen isoquinoline (mixing isomer)"></PatentFamily><PatentFamily id="701531" number="WO-2008094877" title="Compositions for oral delivery of pharmaceuticals"></PatentFamily><PatentFamily id="702006" number="WO-2009006194" title="Pharmaceutical compositions for the treatment of involuntary emotional expression disorder"></PatentFamily><PatentFamily id="722951" number="WO-00182895" title="Guaifenesin sustained release formulation and tablets"></PatentFamily><PatentFamily id="727937" number="CN-01634059" title="Pseudoephedrine hydrochloride, dextromethorphan hydrobromide and chlorphenamine maleates gel formulation and its preparing process"></PatentFamily><PatentFamily id="744772" number="CN-102283840" title="Granule containing dextromethorphan hydrobromide and guaiamar and preparation method thereof"></PatentFamily><PatentFamily id="796402" number="EP-00529898" title="Potentiation of the antitussive effect of dextromethorphan with acetaminophen (paracetamol)"></PatentFamily><PatentFamily id="83886" number="CN-102641258" title="Spongy dextromethorphan hydrobromide film agent with micro-pore and preparation method thereof"></PatentFamily><PatentFamily id="910431" number="WO-09836738" title="Dosage Form Exhibiting Rapid Disperse Properties, Methods Of Use And Process For The Manufacture Of Same"></PatentFamily><PatentFamily id="938919" number="CN-01195517" title="&lt;para&gt;Rationed fenmameimin drops  &lt;/para&gt;"></PatentFamily><PatentFamily id="963406" number="US-20120022009" title="Tannate dry powder formulations"></PatentFamily></PatentFamilies><PatentFamilyCountsByTypes><PatentFamilyCountsByType><Type sortorder="3">Component of Combination</Type><Count>1</Count></PatentFamilyCountsByType><PatentFamilyCountsByType><Type sortorder="5">Formulation</Type><Count>4</Count></PatentFamilyCountsByType></PatentFamilyCountsByTypes><PatentFamilyCountsByCompanies><PatentFamilyCountsByCompany><CompanyLink nameDisplay="Johnson &amp; Johnson" id="17332"></CompanyLink><CountAsOwner>3</CountAsOwner><CountAsThirdParty>0</CountAsThirdParty><CountTotal>3</CountTotal></PatentFamilyCountsByCompany><PatentFamilyCountsByCompany><CompanyLink nameDisplay="Pfizer Inc" id="18767"></CompanyLink><CountAsOwner>1</CountAsOwner><CountAsThirdParty>0</CountAsThirdParty><CountTotal>1</CountTotal></PatentFamilyCountsByCompany><PatentFamilyCountsByCompany><CompanyLink nameDisplay="Novartis AG" id="23137"></CompanyLink><CountAsOwner>1</CountAsOwner><CountAsThirdParty>0</CountAsThirdParty><CountTotal>1</CountTotal></PatentFamilyCountsByCompany></PatentFamilyCountsByCompanies><hasSWOTs>N</hasSWOTs></ns2:com.thomsonreuters.ls.service.contract.soap.drugs.v2.DrugRecordOutput>